Capital Investment Advisors LLC Boosts Stake in CVS Health Co. (NYSE:CVS)

Capital Investment Advisors LLC raised its holdings in shares of CVS Health Co. (NYSE:CVSGet Rating) by 1.6% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 145,513 shares of the pharmacy operator’s stock after acquiring an additional 2,286 shares during the period. Capital Investment Advisors LLC’s holdings in CVS Health were worth $14,727,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of CVS. West Bancorporation Inc. purchased a new position in CVS Health during the fourth quarter worth about $25,000. Claremont Financial Group Inc. purchased a new position in CVS Health during the fourth quarter worth about $26,000. Stuart Chaussee & Associates Inc. boosted its holdings in shares of CVS Health by 123.0% in the 1st quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 171 shares in the last quarter. Capital Advisors Ltd. LLC boosted its holdings in shares of CVS Health by 125.7% in the 4th quarter. Capital Advisors Ltd. LLC now owns 316 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 176 shares in the last quarter. Finally, Steph & Co. boosted its holdings in shares of CVS Health by 138.7% in the 4th quarter. Steph & Co. now owns 358 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 208 shares in the last quarter. Institutional investors and hedge funds own 78.00% of the company’s stock.

CVS opened at $91.29 on Thursday. The business has a 50 day simple moving average of $97.08 and a two-hundred day simple moving average of $101.42. The firm has a market capitalization of $119.71 billion, a price-to-earnings ratio of 15.16, a PEG ratio of 1.44 and a beta of 0.78. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.88 and a quick ratio of 0.62. CVS Health Co. has a one year low of $79.33 and a one year high of $111.25.

CVS Health (NYSE:CVSGet Rating) last released its quarterly earnings results on Wednesday, May 4th. The pharmacy operator reported $2.22 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.08. CVS Health had a return on equity of 15.33% and a net margin of 2.67%. The business had revenue of $76.83 billion during the quarter, compared to analyst estimates of $75.30 billion. During the same quarter in the prior year, the company posted $2.04 EPS. CVS Health’s quarterly revenue was up 11.2% compared to the same quarter last year. As a group, sell-side analysts expect that CVS Health Co. will post 8.34 EPS for the current fiscal year.

A number of equities analysts have recently issued reports on the company. Loop Capital assumed coverage on CVS Health in a report on Thursday, June 16th. They issued a “buy” rating and a $120.00 price objective for the company. StockNews.com assumed coverage on CVS Health in a report on Thursday, March 31st. They issued a “strong-buy” rating for the company. Sanford C. Bernstein cut CVS Health from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $122.00 to $112.00 in a report on Thursday, May 26th. Tigress Financial upped their price objective on CVS Health from $122.00 to $125.00 in a report on Thursday, April 7th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on CVS Health from $110.00 to $113.00 in a research note on Thursday, May 5th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $116.05.

In other news, EVP Daniel P. Finke sold 55,359 shares of the stock in a transaction that occurred on Monday, April 4th. The stock was sold at an average price of $100.13, for a total value of $5,543,096.67. Following the completion of the transaction, the executive vice president now owns 3,098 shares of the company’s stock, valued at approximately $310,202.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Prem S. Shah sold 16,954 shares of the stock in a transaction that occurred on Friday, April 8th. The stock was sold at an average price of $105.00, for a total value of $1,780,170.00. Following the completion of the transaction, the executive vice president now directly owns 43,453 shares of the company’s stock, valued at approximately $4,562,565. The disclosure for this sale can be found here. Insiders sold a total of 77,659 shares of company stock valued at $7,882,993 in the last three months. Corporate insiders own 0.69% of the company’s stock.

About CVS Health (Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Featured Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.